Last updated on September 2017

Tralokinumab monotherapy for moderate to severe atopic dermatitis.


Brief description of study

Tralokinumab monotherapy for moderate to severe atopic dermatitis.

Detailed Study Description

Tralokinumab monotherapy for moderate to severe atopic dermatitis.

Clinical Study Identifier: TX152426

Find a site near you

Start Over

Psoriasis Treatment Center of Central New Jersey

59 One Mile Road Ext. East Windsor, NJ USA
0.32miles
  Connect »